Clinical trial NCT05698199 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-03-01 → 2026-06-01 3. primary completion date: 2026-03-01 → 2026-02-11 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07600723: start date: 2026-06-24 → 2026-07-15.
Clinical trial NCT07318324 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-03 → 2026-05-13
Jackson Named InvestmentNews 2026 Annuities Provider of the Year
EMPLOYERS Appoints Jeffrey P. Lisenby as Executive Vice President, General Counsel
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
Scrip Election/ Distribution/ DRP:
Calix to Post Second Quarter 2026 Results on July 20, 2026
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in interest of Director - Ow Chio Kiat